Literature DB >> 22722403

BET domain co-regulators in obesity, inflammation and cancer.

Anna C Belkina1, Gerald V Denis.   

Abstract

The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helices and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes. Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression. Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets. However, small molecules that inhibit bromodomain and extraterminal (BET) proteins have been described. We examine these developments and discuss the implications for small molecule epigenetic targeting of chromatin networks in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722403      PMCID: PMC3934568          DOI: 10.1038/nrc3256

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  180 in total

1.  Identification of a polymorphic, neuron-specific chromatin remodeling complex.

Authors:  Ivan Olave; Weidong Wang; Yutong Xue; Ann Kuo; Gerald R Crabtree
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

2.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Linkage of LMP, TAP, and RING3 with Mhc class I rather than class II genes in the zebrafish.

Authors:  K Takami; Z Zaleska-Rutczynska; F Figueroa; J Klein
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

4.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  Brd2 disruption in mice causes severe obesity without Type 2 diabetes.

Authors:  Fangnian Wang; Hongsheng Liu; Wanda P Blanton; Anna Belkina; Nathan K Lebrasseur; Gerald V Denis
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

6.  Cloning and molecular characterization of the trithorax locus of Drosophila melanogaster.

Authors:  B A Mozer; I B Dawid
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

Authors:  F Courjal; M Cuny; J Simony-Lafontaine; G Louason; P Speiser; R Zeillinger; C Rodriguez; C Theillet
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

Review 8.  SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions?

Authors:  M J Pazin; J T Kadonaga
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

9.  Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).

Authors:  J C Reyes; J Barra; C Muchardt; A Camus; C Babinet; M Yaniv
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

10.  BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Authors:  C A French; C L Ramirez; J Kolmakova; T T Hickman; M J Cameron; M E Thyne; J L Kutok; J A Toretsky; A K Tadavarthy; U R Kees; J A Fletcher; J C Aster
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

View more
  284 in total

1.  Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.

Authors:  Brandon L Crowe; Ross C Larue; Chunhua Yuan; Sonja Hess; Mamuka Kvaratskhelia; Mark P Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

2.  Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanisms.

Authors:  Xiarong Shi; Valia T Mihaylova; Leena Kuruvilla; Fang Chen; Stephen Viviano; Massimiliano Baldassarre; David Sperandio; Ruben Martinez; Peng Yue; Jamie G Bates; David G Breckenridge; Joseph Schlessinger; Benjamin E Turk; David A Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement.

Authors:  Surojeet Sengupta; Michael C Biarnes; Robert Clarke; V Craig Jordan
Journal:  Breast Cancer Res Treat       Date:  2015-02-27       Impact factor: 4.872

4.  Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.

Authors:  Xia Zhou; Lucy X Fan; Dorien J M Peters; Marie Trudel; James E Bradner; Xiaogang Li
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

5.  miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.

Authors:  Yuki Takagawa; Yasuyuki Gen; Tomoki Muramatsu; Kousuke Tanimoto; Jun Inoue; Hiroyuki Harada; Johji Inazawa
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 11.454

6.  Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis.

Authors:  Zheng Chen; Zheng Li; Mohammed Soutto; Weizhi Wang; M Blanca Piazuelo; Shoumin Zhu; Yan Guo; Maria J Maturana; Alejandro H Corvalan; Xi Chen; Zekuan Xu; Wael M El-Rifai
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

Review 7.  Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors.

Authors:  Minas P Economides; Srdan Verstovsek; Naveen Pemmaraju
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

8.  Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.

Authors:  Chengyue Zhang; Zheng-Yuan Su; Ling Wang; Limin Shu; Yuqing Yang; Yue Guo; Douglas Pung; Chas Bountra; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2016-08-09       Impact factor: 5.858

9.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

10.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.